Marker of small cell cancer of lung is
First, I remember that small cell lung cancer (SCLC) is a neuroendocrine tumor. Neuroendocrine tumors often express certain markers. The key markers for SCLC include CD56, synaptophysin, and chromogranin A. These are part of the neuroendocrine markers. Another marker could be TTF-1 (Thyroid Transcription Factor 1), which is also seen in some lung cancers, but more commonly in non-small cell, like adenocarcinomas.
Wait, but the question is about the specific marker for SCLC. CD56 is definitely a hallmark. Let me confirm: CD56 is a neural cell adhesion molecule, and it's commonly overexpressed in SCLC. Synaptophysin and chromogranin A are also neuroendocrine markers, but CD56 is more specific for SCLC.
Now, for the incorrect options. Let's think about other markers. Cytokeratin 7 (CK7) is found in many lung adenocarcinomas. Napsin A is also a marker for lung adenocarcinoma. Calretinin might be used for mesothelioma. TTF-1 is more for non-small cell. So if the options included any of these, they would be incorrect.
Putting it all together, the core concept is neuroendocrine markers in SCLC. The correct answer is CD56. The other options like TTF-1, CK7, or others are not specific for SCLC. The clinical pearl is to remember that SCLC is neuroendocrine and CD56 is a key marker. Need to structure the explanation with each section as specified.
**Core Concept**
Small cell lung cancer (SCLC) is a neuroendocrine tumor characterized by the expression of specific neuroendocrine markers such as **CD56 (neural cell adhesion molecule)**, **synaptophysin**, and **chromogranin A**. These markers distinguish SCLC from non-small cell lung cancer (NSCLC) and other malignancies.
**Why the Correct Answer is Right**
**CD56** is a hallmark of SCLC due to its role in cell adhesion and signaling in neuroendocrine cells. It is expressed in over 90% of SCLC cases and is rarely seen in NSCLC. Synaptophysin and chromogranin A further support the neuroendocrine differentiation of SCLC, aiding in diagnosis via immunohistochemistry.
**Why Each Wrong Option is Incorrect**
**Option A:** *TTF-1* is a nuclear transcription factor expressed in 70-80% of NSCLC (especially adenocarcinoma) but not in SCLC.
**Option B:** *Cytokeratin 7 (CK7)* is a broad epithelial marker, common in NSCLC and other carcinomas but absent in SCLC.
**Option C:** *Calretinin* is a marker for malignant mesothelioma,